| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/20/2005 | CN1197958C Globule nocardia strain and use of it for removing organic sulfur in fossil fuel |
| 04/20/2005 | CN1197957C Clavibacter and method for fermentation production of L-lysine |
| 04/20/2005 | CN1197956C Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 04/20/2005 | CN1197955C Method for increasing growing and propagating ability of fungus agent in soil |
| 04/20/2005 | CN1197954C Blue-green alga gene transfer method favorable to harvest |
| 04/20/2005 | CN1197953C Method for cultivating nostoc commune |
| 04/20/2005 | CN1197952C Mucor racemosus strain and process for producing fermented bean curd thereby |
| 04/20/2005 | CN1197876C Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 04/20/2005 | CN1197618C Mutant cholera holotoxin as an adjuvant |
| 04/19/2005 | US6881832 Comprises nucleotide sequences coding signal sequences for transport of heterologous proteins into preferential cellular compartments |
| 04/19/2005 | US6881823 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing |
| 04/19/2005 | US6881720 Antimicrobial protein from Lyophyllum shimeji |
| 04/19/2005 | US6881575 Using fluorescent activated cell sorting to separate and isolate cells comprising mutations in cell proliferation; anticarcinogenic agents; antiproliferative agents |
| 04/19/2005 | US6881567 Pre-emergent biological control agents |
| 04/19/2005 | US6881564 Enzymatic peptide comprising modified asparaginic residues for treatment of tumors, infection, liver and autoimmune disorders |
| 04/19/2005 | US6881562 Proteases from gram-positive organisms |
| 04/19/2005 | US6881560 Introducing into a host, for expression of genes encoding enzymes required for synthesis of non-polyhydroxybutyrate and copolymer, a selected genes enzymes in combination of regulatory sequence to express the genes to encode enzymes |
| 04/19/2005 | US6881559 Enzymatic polypeptide for use as amplification tool in genetic engineering |
| 04/19/2005 | US6881556 Nucleotide sequences for use as tools in controlling gene expression in genetic engineering |
| 04/19/2005 | US6881552 Human protease associated proteins |
| 04/19/2005 | US6881541 Method for analyzing a fluid sample |
| 04/19/2005 | US6881410 Treatment of E. faecium infection |
| 04/19/2005 | US6881395 Ligand for use as tool in the treatment of tumors in humans |
| 04/19/2005 | CA2110497C Use of bacterial lipases for producing drugs for maldigestion therapy |
| 04/14/2005 | WO2005033324A1 Biocatalyst for producing d-lactic acid |
| 04/14/2005 | WO2005033322A1 Methods and tools for the chromosomal modification of bacteria |
| 04/14/2005 | WO2005033308A1 Schizophrenia-associated protein and gene coding for the same |
| 04/14/2005 | WO2005033132A2 Igf binding proteins |
| 04/14/2005 | WO2005032591A1 Compositions and methods for augmenting kidney function |
| 04/14/2005 | WO2005032250A2 Chromobacterium suttsuga sp. nov. and use for control of insect pests |
| 04/14/2005 | WO2005018579A3 Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters |
| 04/14/2005 | WO2005003322A3 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 04/14/2005 | WO2004108890A3 Dilute methanol -or ethanol- induced production of polypeptides in microorganisms |
| 04/14/2005 | WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 04/14/2005 | WO2004083378A3 Mammalian cell lines specifically deficient in o-linked glycosylation |
| 04/14/2005 | WO2004047612A3 Methods of therapy and diagnosis |
| 04/14/2005 | WO2004022764A9 Use of malate dehydrogenase for nadh regeneration |
| 04/14/2005 | WO2004014295A3 Tiacumicin production |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | WO2003009698A3 Direct-fed microbial |
| 04/14/2005 | WO2002079417A3 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 04/14/2005 | US20050080247 Leinamycin biosynthesis gene cluster and its components and their uses |
| 04/14/2005 | US20050080233 Expression vector comprising nucleotide sequences coding bacterial outer membrane protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 04/14/2005 | US20050080032 Modulating expression of an endogenous marine invertebrate gene or an endogenous gene in a pathogen that infects marine invertebrate by administering to invertebrate at least one dsRNA that comprises a sequence having substantial sequence homology to the endogenous pathogen gene |
| 04/14/2005 | US20050080014 Thrombopoietic compounds |
| 04/14/2005 | US20050079978 From Phoma isolates, extracts, broth; broad leaf |
| 04/14/2005 | US20050079956 Ice skating training apparatus for playing hockey |
| 04/14/2005 | US20050079618 Host cells deficient for mismatch repair and their use in methods for inducing homologous recombination using single-stranded nucleic acids |
| 04/14/2005 | US20050079617 Increasing carbon flow into a metabolic pathway of a phosphotransferase transport system, glucose transport double mutant via transformation and expression with vector comprising galactose permease and glucokinase activity; bioreactor and heterologous gene expression |
| 04/14/2005 | US20050079605 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/14/2005 | US20050079597 Antimicrobial composition |
| 04/14/2005 | US20050079596 Nitrite-oxidizing bacteria and methods of using and detecting the same |
| 04/14/2005 | US20050079595 Expression vector comprising nucleotide sequences coding hydrolase for use in generating enantimorphic carboxylic acid; agrochemicals and pharmeceuticals; drug design |
| 04/14/2005 | US20050079590 Bio-based method for making mannitol |
| 04/14/2005 | US20050079588 Using gramnegative bacteria transgenic for nitrogen metabolizing genes as bioreactor for fermentation of lysine for use in medicine, cosmetics and animal feeds |
| 04/14/2005 | US20050079586 Enzymatic polypeptide for use as tool in production of D-ribulose-5-phosphate in bacteria; bioreactors |
| 04/14/2005 | US20050079583 Mammalian Zcytor 11 |
| 04/14/2005 | US20050079582 chimeric polypeptide molecules inhibits neoplastic cell growth or inhibits endothelial cell growth |
| 04/14/2005 | US20050079581 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 04/14/2005 | US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics |
| 04/14/2005 | US20050079570 Culture medium for rapid detection of mycobacterial growth by color change |
| 04/14/2005 | US20050079539 Novel gene encoding brain specific membrane protein |
| 04/14/2005 | US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents |
| 04/14/2005 | US20050079537 Expression vector comprising nucleotide sequences coding membrane protein for in identifying modulator for prevention and treatment of cell proliferative, nervous system and inflammatory disorders |
| 04/14/2005 | US20050079525 Long wavelength engineered fluorescent proteins |
| 04/14/2005 | US20050079498 Expression vector comprising nucleotide sequences coding polypeptide associated with clavam compounds for use in transformation and generation of cells with improved clavulanic acid production |
| 04/14/2005 | US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders |
| 04/14/2005 | US20050079488 For use in expression constructs for expressing gene products, and methods of using it |
| 04/14/2005 | US20050079173 Antibody that binds said inhibitor protein; interfering diagnostically or therapeutically with a wnt signal path; treatment of eye disorders, bone disorders, or tumors |
| 04/14/2005 | US20050079170 Expression vectors coding antigen binding structure; mixture of protein monomers |
| 04/14/2005 | US20050079157 Combination bacteriolytic therapy for the treatment of tumors |
| 04/14/2005 | US20050076850 Live water compositions for bio-cycling of aquariums |
| 04/14/2005 | DE10344739A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien A process for the fermentative preparation of L-amino acids using coryneform bacteria |
| 04/14/2005 | DE10344545A1 New isolated, truncated capsid protein C1 of beak and feather disease virus, useful in vaccines and as a diagnostic agent, and its encoding nucleic acid |
| 04/14/2005 | CA2541015A1 Igf binding proteins |
| 04/14/2005 | CA2540467A1 Compositions and methods for augmenting kidney function |
| 04/13/2005 | EP1522590A1 Methods for producing modified glycoproteins |
| 04/13/2005 | EP1522588A2 Accessory functions for use in recombinant AAV virion production |
| 04/13/2005 | EP1522579A2 Hyaluronan synthase gene and uses thereof |
| 04/13/2005 | EP1522578A1 Transferring materials into cells using porous silicon |
| 04/13/2005 | EP1521832A2 Genes |
| 04/13/2005 | EP1521828A2 Production of polyketides |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521767A2 Methods and constructs for high yield expression of clostripain |
| 04/13/2005 | EP1521766A2 SPLICEOSOME MEDIATED RNA i TRANS /i -SPLICING AND CORRECTION OF FACTOR VIII GENETIC DEFECTS USING SPLICEOSOME MEDIATED RNA TRANS SPLING |
| 04/13/2005 | EP1521765A1 Bafilomycin-like metabolite from a novel micromonospora species |
| 04/13/2005 | EP1239813B1 Extract of blue-green alga spirulina and the use thereof in cosmetic skin-care and body care agents |
| 04/13/2005 | EP1210441B1 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 04/13/2005 | EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/13/2005 | EP1180153B1 Phage-dependent super-production of biologically active proteins and peptides |
| 04/13/2005 | EP0938555B1 Constructs and complexes of cyclin e |
| 04/13/2005 | CN1606626A Novel alkaline protease from bacillius sp. (DSM 14390) and washing and cleaning products comprising said novel alkaline protease |
| 04/13/2005 | CN1606619A Novel alkaline protease from bacillus gibsonii (DSM 14391) and washing and cleaning agents containing said novel alkaline protease |
| 04/13/2005 | CN1606618A Novel alkali protease formed by bacillus gibsonii (DSM 14393) and washing and cleaning agents containing said novel alkali protease |
| 04/13/2005 | CN1606617A Alleles of the siga gene from coryneform bacteria |
| 04/13/2005 | CN1606569A Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 04/13/2005 | CN1606567A Antimicrobial polypeptides from pseudoplectania nigrella |
| 04/13/2005 | CN1606565A Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/13/2005 | CN1605629A Non-structural protein gene 3ABC of foot-and-mouth disease virus and its preparation and use |